You are here

Metagenomi

Biopharma IPOs From the First Half of 2024

BioSpace

Thu, 05/30/24 - 11:17 am

Kyverna Therapeutics

ArriVent Biopharma

Alto Neuroscience

Contineum Therapeutics

Rapport Therapeutics

Telix Pharmaceuticals

Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight

Fierce Biotech

Thu, 05/2/24 - 10:17 pm

Moderna Therapeutics

Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut

BioSpace

Mon, 02/12/24 - 11:51 am

Gene editing biotech Metagenomi pulls off nearly $94M IPO

BioPharma Dive

Sun, 02/11/24 - 03:52 pm

2024 Brings Surprising Early Surge of Biotech IPOs

BioSpace

Fri, 01/19/24 - 09:43 am

Alto Neuroscience

ArriVent Biopharma

Kyverna Therapeutics

Gene editing startup Metagenomi files for an IPO

BioPharma Dive

Sun, 01/7/24 - 04:16 pm

5 Life Sciences IPOs in 2023—and the Future Forecast

BioSpace

Wed, 09/20/23 - 08:51 am

Neumora Therapeutics

New Funding Led by Moderna, Bayer, Brings Metagenomi's Series B to $275M

BioSpace

Fri, 01/6/23 - 09:39 am

Moderna Therapeutics

Ionis gets into gene editing

EP Vantage

Mon, 11/14/22 - 10:39 am

Ionis Pharmaceuticals

Gene editing startup Metagenomi raises $175M to advance research pipeline

BioPharma Dive

Tue, 01/25/22 - 10:55 am

Moderna Therapeutics

Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data

Fierce Biotech

Tue, 11/2/21 - 10:46 am

Moderna Therapeutics

Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push

Fierce Biotech

Wed, 04/7/21 - 10:37 am

venture capital

Bayer powers gene-editing startup Metagenomi to $65M A round

Fierce Biotech

Thu, 11/12/20 - 10:55 am